GB2124234B - Antitumor antibiotic - Google Patents

Antitumor antibiotic

Info

Publication number
GB2124234B
GB2124234B GB08320026A GB8320026A GB2124234B GB 2124234 B GB2124234 B GB 2124234B GB 08320026 A GB08320026 A GB 08320026A GB 8320026 A GB8320026 A GB 8320026A GB 2124234 B GB2124234 B GB 2124234B
Authority
GB
United Kingdom
Prior art keywords
antitumor antibiotic
antitumor
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08320026A
Other languages
English (en)
Other versions
GB8320026D0 (en
GB2124234A (en
Inventor
Masataka Konishi
Fumihide Sakai
Takeo Miyaki
Hiroshi Kawaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GB8320026D0 publication Critical patent/GB8320026D0/en
Publication of GB2124234A publication Critical patent/GB2124234A/en
Application granted granted Critical
Publication of GB2124234B publication Critical patent/GB2124234B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/825—Actinomadura

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08320026A 1982-07-26 1983-07-25 Antitumor antibiotic Expired GB2124234B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40146882A 1982-07-26 1982-07-26

Publications (3)

Publication Number Publication Date
GB8320026D0 GB8320026D0 (en) 1983-08-24
GB2124234A GB2124234A (en) 1984-02-15
GB2124234B true GB2124234B (en) 1986-04-03

Family

ID=23587892

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08320026A Expired GB2124234B (en) 1982-07-26 1983-07-25 Antitumor antibiotic

Country Status (29)

Country Link
JP (1) JPS5948084A (el)
KR (1) KR840005484A (el)
AU (1) AU567105B2 (el)
BE (1) BE897381A (el)
CA (1) CA1215337A (el)
CH (1) CH657778A5 (el)
CS (1) CS251077B2 (el)
DD (1) DD210075A5 (el)
DE (1) DE3326917A1 (el)
DK (1) DK339683A (el)
ES (1) ES524405A0 (el)
FI (1) FI832676A (el)
FR (1) FR2530663A1 (el)
GB (1) GB2124234B (el)
GR (1) GR78648B (el)
HU (1) HU192165B (el)
IE (1) IE55800B1 (el)
IL (1) IL69313A0 (el)
IT (1) IT1163847B (el)
LU (1) LU84930A1 (el)
MY (1) MY8800125A (el)
NL (1) NL8302610A (el)
NO (1) NO832689L (el)
NZ (1) NZ204965A (el)
OA (1) OA07503A (el)
PT (1) PT77091B (el)
SE (1) SE8304132L (el)
YU (1) YU158583A (el)
ZA (1) ZA835337B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208013A (en) * 1983-05-16 1987-07-31 Bristol Myers Co Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora
JPS606194A (ja) * 1983-06-23 1985-01-12 Meiji Seika Kaisha Ltd 新規抗生物質ｓｆ−２２８８及びその製造法
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex
US5304373A (en) * 1991-10-22 1994-04-19 Bristol-Myers Squibb Co. Antitumor antibiotic

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148882A (en) * 1977-06-24 1979-04-10 Pfizer Inc. Polycyclic ether antibiotics produced by new species of actinomycete
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation
CA1198386A (en) * 1981-10-22 1985-12-24 Donald B. Borders ANTIBACTERIAL AGENTS LL-C23024.beta. AND IOTA AND MICROORGANISM ACTINOMADURA YUMAENSE NRRL 12515
US4578271A (en) * 1982-05-24 1986-03-25 Fujisawa Pharmaceutical Co., Ltd. Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
NZ208013A (en) * 1983-05-16 1987-07-31 Bristol Myers Co Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora

Also Published As

Publication number Publication date
JPS5948084A (ja) 1984-03-19
NO832689L (no) 1984-01-27
CA1215337A (en) 1986-12-16
IE831740L (en) 1984-01-26
AU567105B2 (en) 1987-11-12
ES8502161A1 (es) 1984-12-16
IT8322219A0 (it) 1983-07-25
SE8304132L (sv) 1984-01-27
NZ204965A (en) 1986-09-10
MY8800125A (en) 1988-12-31
DK339683D0 (da) 1983-07-25
CH657778A5 (de) 1986-09-30
IE55800B1 (en) 1991-01-16
IL69313A0 (en) 1983-11-30
BE897381A (fr) 1984-01-26
PT77091A (en) 1983-08-01
DE3326917A1 (de) 1984-02-02
HUT37167A (en) 1985-11-28
KR840005484A (ko) 1984-11-14
FR2530663A1 (fr) 1984-01-27
FI832676A (fi) 1984-01-27
IT1163847B (it) 1987-04-08
FI832676A0 (fi) 1983-07-22
HU192165B (en) 1987-05-28
ZA835337B (en) 1984-03-28
GR78648B (el) 1984-09-27
GB8320026D0 (en) 1983-08-24
SE8304132D0 (sv) 1983-07-25
LU84930A1 (fr) 1984-03-22
ES524405A0 (es) 1984-12-16
YU158583A (en) 1985-12-31
DK339683A (da) 1984-01-27
NL8302610A (nl) 1984-02-16
CS251077B2 (en) 1987-06-11
GB2124234A (en) 1984-02-15
JPH0526799B2 (el) 1993-04-19
AU1720083A (en) 1984-02-02
PT77091B (en) 1986-06-26
OA07503A (en) 1985-03-31
DD210075A5 (de) 1984-05-30

Similar Documents

Publication Publication Date Title
CY1534A (en) Bbm-2478 antibiotic complex
ZA837974B (en) Xenorhabdin antibiotics
ZA827721B (en) Antibiotic
GB2160529B (en) Antitumor antibiotic compound
GB8307807D0 (en) Antibiotics
GB8324134D0 (en) Antibiotic acmimycin
GB8412368D0 (en) Antitumor antibiotic complex
GB2152028B (en) Antitumor antibiotic
GB2124234B (en) Antitumor antibiotic
GB2124226B (en) Antibiotic
GB8430613D0 (en) Antibiotic
JPS5781488A (en) 1-oxa-beta-lactam antibiotic
DE3365127D1 (en) Antitumor agent
GB2132604B (en) Antitumor antibiotic awamycin
ZA831461B (en) Antibiotics
GB8426115D0 (en) Antibiotic ll-c23024
GB8305155D0 (en) Anthracycline antibiotic
GB8311156D0 (en) Anti-tumor compounds
GB2113672B (en) Antibiotic
GB8528958D0 (en) Antibiotics
ZA834472B (en) Carbepenem antibiotics
GB8412129D0 (en) Antibiotic cepacin
JPS57179163A (en) Antitumor
IL93419A (en) Antitumor antibiotics ll-e33288beta-i
DE3170183D1 (en) Antibiotic 5057b

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee